Clinical Trial Update: Pilot Study of Betahistine Dihydrochloride in the Treatment of Major Depression With Atypical Features [Phase 2]

View source ↗

Summary

Phase 2 pilot study evaluating betahistine dihydrochloride for recurrent major depressive disorder with atypical features was terminated. Results were posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder Recurrent with Atypical Features

Drugs mentioned

• Betahistine Dihydrochloride (betahistine dihydrochloride)

Snippet

Sponsor: University of Cincinnati | Conditions: Recurrent Major Depressive Disorder With Atypical Features | Phase 2 | Status: TERMINATED | Results posted: 2017-07-25